Kumar Dinesh M. 4

4 · Astrana Health, Inc. · Filed Jan 27, 2026

AI-generated summary of this filing

Updated Jan 27, 2026

Astrana Health (ASTH) CMO Kumar Dinesh Surrenders 10,759 Shares

What Happened

Kumar Dinesh, Chief Medical Officer of Astrana Health (ASTH), surrendered 10,759 shares on January 23, 2026 to satisfy tax withholding obligations related to restricted stock that vested the same day. The shares were valued at $27.16 each, totaling approximately $292,214. This was a tax-withholding disposition (code F), not an open-market sale.

Key Details

Transaction date: January 23, 2026; Filing date: January 27, 2026 (filed 4 days after the transaction; Form 4s are typically due within 2 business days, so this filing appears later than usual).
Disposition: 10,759 shares surrendered for tax withholding at $27.16 per share; total value ≈ $292,214.
Transaction code: F (shares withheld/surrendered to satisfy tax obligations).
Shares owned after transaction: not specified in the provided filing excerpt.
Footnotes of note:
- F1: Shares surrendered to offset tax withholding on restricted stock that vested Jan 23, 2026.
- F2: Ongoing unvested awards include 28,378 RS that vest Jan 23, 2027; performance-based grants of 8,158 and 3,264 RS; 67,238 RSUs tied to performance; and 23,364 RSUs vesting in seven semi-annual installments beginning Mar 5, 2026 (all subject to continued employment and any performance conditions).
- F3: Includes 1,405 shares acquired under the company’s Employee Stock Purchase Plan.

Context

This was a tax-withholding action (a common, routine disposition) accompanying the vesting of restricted stock—effectively a “cashless” way to pay withholding taxes—so it does not necessarily indicate the insider is selling for investment reasons or signaling a view on the company.
The filing timing may be later than the usual Form 4 reporting window; investors tracking insider activity should note the delay but treat this transaction as administrative rather than a typical insider sale.

Form 4

Period: 2026-01-23

Chief Medical Officer

Transactions

Tax Payment
Common Stock
[F1][F2][F3]
2026-01-23$27.16/sh−10,759$292,214→ 202,032 total

Footnotes (3)

[F1]Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on January 23, 2026.
[F2]Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 28,378 shares, which will vest on January 23, 2027; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.
[F3]Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.

Signature

/s/ Kathy Diep, as Attorney-in-Fact|2026-01-27

1 file